Primary Pseudomyogenic Hemangioendothelioma of the Cranium: Findings on FDG-PET/CT

Jie Liu1, Xin Li, Rui Zhou

  • 1Department of Nuclear Medicine, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.

Clinical Nuclear Medicine
|February 23, 2026
PubMed

Insights

Pseudomyogenic hemangioendothelioma (PMH) is a rare vascular neoplasm. This case report details a unique occipital bone presentation of PMH in a 54-year-old male, confirmed by surgical pathology.

Area of Science:

  • Oncology
  • Vascular Neoplasms
  • Pathology

Background:

  • Pseudomyogenic hemangioendothelioma (PMH) is an extremely rare intermediate-grade vascular neoplasm.
  • It typically affects the distal extremities and occurs in younger individuals.
  • This neoplasm has a male predominance.

Purpose of the Study:

  • To report an unusual case of PMH presenting as an occipital mass.
  • To describe the imaging and pathological findings of this rare presentation.

Main Methods:

  • Case report of a 54-year-old male with an occipital mass.
  • Imaging studies including contrast-enhanced CT and FDG PET/CT were performed.
  • Diagnosis was confirmed by surgical pathology.

Main Results:

  • The occipital mass was expansile, well-circumscribed, and lytic, with adjacent scalp and subcutaneous nodules.
  • Imaging showed marked enhancement and high FDG uptake.
  • Surgical pathology confirmed the diagnosis of PMH.

Conclusions:

  • PMH can present atypically, including in the skull.
  • Multimodality imaging is crucial for characterizing PMH.
  • Surgical pathology remains the gold standard for diagnosis.